QSAR STUDY OF HCV NS5B POLYMERASE INHIBITORS USING THE GENETIC ALGORITHM-MULTIPLE LINEAR REGRESSION (GA-MLR)

被引:0
|
作者
Rafiei, Hamid [1 ]
Khanzadeh, Marziyeh [2 ]
Mozaffari, Shahla [2 ]
Bostanifar, Mohammad Hassan [1 ]
Avval, Zhila Mohajeri [2 ]
Aalizadeh, Reza [3 ]
Pourbasheer, Eslam [2 ]
机构
[1] Islamic Azad Univ, Dashtestan Branch, Dept Chem, Dashtestan, Iran
[2] PNU, Dept Chem, POB 19395-3697, Tehran, Iran
[3] Univ Athens, Dept Chem, Analyt Chem Lab, Athens 15771, Greece
来源
EXCLI JOURNAL | 2016年 / 15卷
关键词
QSAR; Genetic algorithms; Multiple linear regression; HCV; HEPATITIS-C; RNA-POLYMERASE; IDENTIFICATION; ANTAGONISTS; PREVENTION; PREDICTION; STRATEGY; THERAPY; INDEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quantitative structure-activity relationship (QSAR) study has been employed for predicting the inhibitory activities of the Hepatitis C virus (HCV) NS5B polymerase inhibitors. A data set consisted of 72 compounds was selected, and then different types of molecular descriptors were calculated. The whole data set was split into a training set (80 % of the dataset) and a test set (20 % of the dataset) using principle component analysis. The stepwise (SW) and the genetic algorithm (GA) techniques were used as variable selection tools. Multiple linear regression method was then used to linearly correlate the selected descriptors with inhibitory activities. Several validation technique including leave-one-out and leave-group-out cross-validation, Y-randomization method were used to evaluate the internal capability of the derived models. The external prediction ability of the derived models was further analyzed using modified r(2), concordance correlation coefficient values and Golbraikh and Tropsha acceptable model criteria's. Based on the derived results (GA-MLR), some new insights toward molecular structural requirements for obtaining better inhibitory activity were obtained.
引用
收藏
页码:38 / 53
页数:16
相关论文
共 50 条
  • [31] NS5B polymerase inhibitors in phase II clinical trials for HCV infection
    Borgia, Guglielmo
    Maraolo, Alberto Enrico
    Nappa, Salvatore
    Gentile, Ivan
    Buonomo, Antonio Riccardo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 243 - 250
  • [32] Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase
    Cheng, Cliff C.
    Huang, Xiaohua
    Shipps, Gerald W., Jr.
    Wang, Yu-Sen
    Wyss, Daniel F.
    Soucy, Kyle A.
    Jiang, Chuan-kui
    Agrawal, Sony
    Ferrari, Eric
    He, Zhiqing
    Huang, H-C
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 466 - 471
  • [33] Neohexyl derivatives of B-ring alkylaminobenzothiadiazine inhibitors of HCV NS5B polymerase
    Randolph, John T.
    Huang, Peggy P.
    Hutchinson, Douglas K.
    Klein, Larry L.
    Montgomery, Debra A.
    Masse, Sherie V.
    Kati, Warren M.
    Beno, David
    Kempf, Dale J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 730 - 730
  • [34] QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors
    Singh, Neelu
    Shaik, Basheerulla
    Agrawal, Neeraj
    Anita, K.
    Agrawal, Vijay K.
    Gupta, Satya P.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (08) : 757 - 770
  • [35] Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors
    Golub, Andriy G.
    Gurukumar, K. R.
    Basu, Amartya
    Bdzhola, Volodymyr G.
    Bilokin, Yaroslav
    Yarmoluk, Sergiy M.
    Lee, Jin-Ching
    Talele, Tanaji T.
    Nichols, Daniel B.
    Kaushik-Basu, Neerja
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 58 : 258 - 264
  • [36] Synthesis and SAR studies on rhodanine analogs as inhibitors of HCV NS5B polymerase
    Kulkarni, Shridhar
    Patel, Maulik R.
    Chudayeu, Maksim
    Kaushik, Neerja
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [37] Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase
    Wang, Zhiguo
    Chen, Zhenming
    Li, Jianfeng
    Huang, Jing
    Zheng, Chenni
    Liu, Jun-Ping
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (04): : 1071 - 1082
  • [38] Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate
    McKercher, G
    Beaulieu, PL
    Lamarre, D
    LaPlante, S
    Lefebvre, S
    Pellerin, C
    Thauvette, L
    Kukolj, G
    NUCLEIC ACIDS RESEARCH, 2004, 32 (02) : 422 - 431
  • [39] Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase
    Parcella, Kyle
    Nickel, Andrew
    Beno, Brett R.
    Sheriff, Steven
    Wan, Changhong
    Wang, Ying-Kai
    Roberts, Susan B.
    Meanwell, Nicholas A.
    Kadow, John F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (02) : 295 - 298
  • [40] Synthesis of New 4, 5-Dihydrofuranoindoles and Their Evaluation as HCV NS5B Polymerase Inhibitors
    Velazquez, Francisco
    Venkatraman, Srikanth
    Lesburg, Charles A.
    Duca, Jose
    Rosenblum, Stuart B.
    Kozlowski, Joseph A.
    Njoroge, F. George
    ORGANIC LETTERS, 2012, 14 (02) : 556 - 559